Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System...
-
Upload
owen-goodwin -
Category
Documents
-
view
215 -
download
0
Transcript of Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System...
![Page 1: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.](https://reader036.fdocuments.us/reader036/viewer/2022082610/56649da75503460f94a92f8d/html5/thumbnails/1.jpg)
Post-Event HypothermiaPost-Event Hypothermia
Julie Swain M.D.
Cardiovascular SurgeonConsultant to the FDA
Circ System Devices Advisory PanelSept 2004
DRAFT slides
![Page 2: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.](https://reader036.fdocuments.us/reader036/viewer/2022082610/56649da75503460f94a92f8d/html5/thumbnails/2.jpg)
Swain 2
Outline of Presentation
1. Post-event hypothermia in MI
2. Post-event hypothermia in head trauma
3. Post-event hypothermia in resuscitation
4. ILCOR recommendations
5. Questions for panel
![Page 3: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.](https://reader036.fdocuments.us/reader036/viewer/2022082610/56649da75503460f94a92f8d/html5/thumbnails/3.jpg)
Swain 3
Post-Event Hypothermia in Myocardial Infarction
(Cool-MI Study)
• Data presented at TCT 2003(www.radiantmedical.com/download/TCT-ONeill.pdf)
• Prospective, randomized (cooling with IVC catheter vs normothermia during PCI)
• MI < 6 hrs, cool to 33°C for 3 hrs
• Quantitative Endpoint – infarct size at 30 days
![Page 4: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.](https://reader036.fdocuments.us/reader036/viewer/2022082610/56649da75503460f94a92f8d/html5/thumbnails/4.jpg)
Swain 4
COOL-MI Study Results
13.8 % 14.1 %
0
10
20
30
control hypo T
% LVInfarctSize
N = 180 N = 177
p = N.S.
Data presented at TCT 2003(www.radiantmedical.com/download/TCT-ONeill.pdf
![Page 5: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.](https://reader036.fdocuments.us/reader036/viewer/2022082610/56649da75503460f94a92f8d/html5/thumbnails/5.jpg)
Swain 5
COOL-MI Results
Complication Control
(n=180)
Hypo T (33°)
(n=177)
Death 2.2% 3.4%
Vascular/bleeding 15.6% 19.2%
DVT 0 1.7%
Shock 6.1% 12.4%
Pulm Edema 1.7% 3.4%
P = n.s. for all complications, not powered to assess MACE
Data presented at TCT 2003(www.radiantmedical.com/download/TCT-ONeill.pdf
![Page 6: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.](https://reader036.fdocuments.us/reader036/viewer/2022082610/56649da75503460f94a92f8d/html5/thumbnails/6.jpg)
Swain 6
Post-Event Hypothermia in Brain Injury
(Clifton GL, et al. Lack of Effect of Induction of Hypothermia after Acute Brain Injury. N Engl J Med 2001; 344: 556-63)
• Prospective, randomized, surface and GI cooling vs normothermia
• Injury < 6 hrs, cool to 33°C for 48 hrs• Endpoint – Glasgow Outcome Score at 6
months (functional independence with mild or moderate disability)
• Secondary endpoints of psychometric tests
![Page 7: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.](https://reader036.fdocuments.us/reader036/viewer/2022082610/56649da75503460f94a92f8d/html5/thumbnails/7.jpg)
Swain 7
Secondary Endpoints in Brain Injury Trial (at 6 mos)
• Neurobehavioral Rating Scale – Revised• Disability Rating Scale• Galveston Orientation and Amnesia test• Selective Reminding Test• Rey-Osterrieth Complex Figure Test• Symbol Digit Modalities Test• Trail Making Test B• Controlled Oral Word Association Test• Grooved Pegboard Test
![Page 8: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.](https://reader036.fdocuments.us/reader036/viewer/2022082610/56649da75503460f94a92f8d/html5/thumbnails/8.jpg)
Swain 8
Brain Injury Outcome
0
25
50
75
100
Control HypoT
% of PatientsPoor Outcome
N = 193 N = 199
p = N.S.
p = N.S. for all secondary endpoints
57% 57%
![Page 9: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.](https://reader036.fdocuments.us/reader036/viewer/2022082610/56649da75503460f94a92f8d/html5/thumbnails/9.jpg)
Swain 9
Brain Injury Study Results
Complication Control
(n=193)
HypoT
(n=199)Critical Hypotension 3% 10%
Bradycardia w hypotension 4% 16% p = .04
% of hosp. days with complications
70% 78%
p = .01
p = .005
![Page 10: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.](https://reader036.fdocuments.us/reader036/viewer/2022082610/56649da75503460f94a92f8d/html5/thumbnails/10.jpg)
Swain 10
Post-Event HypothermiaCardiac Arrest
• Bernard SA, et al. Treatment of Comatose Survivors of Out-of-Hospital Cardiac Arrest with Induced Hypothermia. N Engl J Med 2002; 346:557-63 [Australia]
• The Hypothermia After Cardiac Arrest Study
Group. Mild Therapeutic Hypothermia to Improve the Neurologic Outcome after Cardiac Arrest. N Engl J Med 2002; 346:549-56 [Europe]
![Page 11: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.](https://reader036.fdocuments.us/reader036/viewer/2022082610/56649da75503460f94a92f8d/html5/thumbnails/11.jpg)
Swain 11
Comparison of Cardiac Arrest Studies
Location Australia Europe
# hypoT pts 43 136
Inclusion
Criteria
VF, return Spon Circ, coma, men>18 yrs, women >50 yrs
Witnessed arrest, VF, VT, cardiac origin, 18-75 yrs, 5-15 min to resuscitation by medical personnel, <60 min from arrest to restore circ ***
***91% of screened pts not eligible
![Page 12: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.](https://reader036.fdocuments.us/reader036/viewer/2022082610/56649da75503460f94a92f8d/html5/thumbnails/12.jpg)
Swain 12
Comparison of Cardiac Arrest Studies
Australia Europe
When cooling started
In field Hospital admission
Cooling method Cold packs then ice packs
Air-cooled mattress, ice packs
Target Duration hypoT
12 hrs 24 hrs
Target Temp 33° 32-34°
![Page 13: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.](https://reader036.fdocuments.us/reader036/viewer/2022082610/56649da75503460f94a92f8d/html5/thumbnails/13.jpg)
Swain 13
Comparison of Cardiac Arrest Studies
Australia Europe
Rewarming Active Passive
Adjunctive meds Midazolam
Vercuronium
Midazolam
Fentanyl
pancuronium
![Page 14: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.](https://reader036.fdocuments.us/reader036/viewer/2022082610/56649da75503460f94a92f8d/html5/thumbnails/14.jpg)
Swain 14
Comparison of Cardiac Arrest Studies
Australia Europe
Primary
Endpoint
survival to hospital discharge with neuro function allowing home or rehabilitation
CPC good or moderate disability at 6 mos
![Page 15: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.](https://reader036.fdocuments.us/reader036/viewer/2022082610/56649da75503460f94a92f8d/html5/thumbnails/15.jpg)
Swain 15
Comparison of Cardiac Arrest Studies
26%
49%
39%
55%
0
25
50
75
100
control hypo T control hypo T
% successendpoint
{Australia} {Europe}
p = .046
(***risk ratio 1.40, CI 1.08 – 1.81)
***
![Page 16: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.](https://reader036.fdocuments.us/reader036/viewer/2022082610/56649da75503460f94a92f8d/html5/thumbnails/16.jpg)
Swain 16
Comparison of Cardiac Arrest Studies
68%
51% 55%
41%
0
25
50
75
100
control hypo T control hypo T
% mortality
{Australia}
{Europe}
***
(***risk ratio 0.74, CI .58 - .95)
p = N.S.
![Page 17: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.](https://reader036.fdocuments.us/reader036/viewer/2022082610/56649da75503460f94a92f8d/html5/thumbnails/17.jpg)
Swain 17
ILCOR Recommendations(ILCOR Advisory Statement. Therapeutic Hypothermia after
Cardiac Arrest. Circulation 2003;108:18-21)
• Unconscious adult patients with spontaneous circulation after out-of-hospital cardiac arrest should be cooled to 32°C to 34°C for 12 to 24 hours when the initial rhythm was ventricular fibrillation (VF).
• Such cooling may also be beneficial for other rhythms or in-hospital cardiac arrest.
![Page 18: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.](https://reader036.fdocuments.us/reader036/viewer/2022082610/56649da75503460f94a92f8d/html5/thumbnails/18.jpg)
Swain 18
Safety Profile of Cooling Methods• Surface
– Cool air– Water cooling– Head and neck cooling
• GI lavage
• Endovascular– Extracorporeal Circulation
• Cardiopulmonary Bypass• Veno-venous• Arterial venous
– IVC catheters
![Page 19: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.](https://reader036.fdocuments.us/reader036/viewer/2022082610/56649da75503460f94a92f8d/html5/thumbnails/19.jpg)
Swain 19
Summary
• Is post-event hypothermia the standard for treating out-of-hospital arrest patients in the U.S.?
• Is surface-induced hypothermia comparable to endovascular hypothermia in safety and efficacy?